{
    "title": "Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk",
    "url": "https://www.dailymail.co.uk/wires/ap/article-12307219/Second-Alzheimers-drug-pipeline-promises-slow-worsening-safety-concern.html",
    "date": "2023-07-17",
    "keywords": [
        "study",
        "donanemab",
        "drug",
        "brain",
        "disease",
        "leqembi",
        "approval",
        "concern",
        "jama",
        "year",
        "tau",
        "treatment",
        "lillys",
        "dr",
        "conference",
        "amyloid",
        "buildup",
        "safety",
        "widera",
        "university",
        "half",
        "doesnt",
        "evidence",
        "mintun",
        "science",
        "washington",
        "worsening",
        "co",
        "food",
        "administration",
        "mindrobbing",
        "drugmaker",
        "hope",
        "john",
        "amsterdam",
        "cure",
        "monday",
        "journal",
        "association",
        "iv",
        "swelling",
        "bleeding",
        "lilly",
        "sign",
        "indianapolis",
        "april",
        "research",
        "era",
        "benefit",
        "theyll",
        "risk",
        "inexpensive",
        "simple",
        "none",
        "editorial",
        "something",
        "cause",
        "culprit",
        "decline",
        "difference",
        "report",
        "way",
        "version",
        "quarter",
        "therapy",
        "repeat",
        "possibility",
        "comparison",
        "stoppage",
        "mark",
        "sort",
        "vengeance",
        "studys",
        "jennifer",
        "manly",
        "columbia",
        "lack",
        "promising",
        "interest",
        "latestage",
        "press",
        "health",
        "department",
        "support",
        "howard",
        "group",
        "ap",
        "content"
    ],
    "category": [
        "wires",
        "ap"
    ]
}